Oncode Oncology Bridge Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
14
- Portfolio
-
7
- Exits
-
2
Oncode Oncology Bridge Fund General Information
Company Description
Founded in 2018, Oncode Oncology Bridge Fund is a venture capital fund based in Utrecht, Netherlands. The firm seeks to invest in early stage companies operating in the Oncology sector.
Business Details
Year Founded
Investor Status
Primary Investor Type
Corporate Office
- HI-FIVE 5th floor
- Jaarbeursplein 6
- 3521 AL Utrecht
- Netherlands
Oncode Oncology Bridge Fund Investments (14)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Laigo Bio | 20-Mar-2026 | Seed Round | Drug Discovery | Generating Revenue | ||
| Cyclomics | 07-Jan-2026 | Biotechnology | Generating Revenue | |||
| Flindr Therapeutics | 28-Mar-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Simmunext Biotherapeutics | 09-Aug-2023 | Biotechnology | Startup | |||
| Cyclomics | 03-Mar-2023 | Biotechnology | Generating Revenue | |||
| Single Cell Discoveries | 01-May-2022 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| Laigo Bio | 08-Feb-2022 | Drug Discovery | Generating Revenue | |||
| Simmunext Biotherapeutics | 01-Jan-2022 | Biotechnology | Startup | |||
| Flindr Therapeutics | 01-Nov-2021 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
| Flindr Therapeutics | 01-Sep-2020 | Seed Round | Drug Discovery | Pre-Clinical Trials |
Oncode Oncology Bridge Fund Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Cyclomics | 01-Feb-2024 | Merger/Acquisition | |
| Single Cell Discoveries |
Oncode Oncology Bridge Fund Investments by Industry, Year, and Region
Oncode Oncology Bridge Fund Co-Investors (20)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Curie Capital | 2 |
|
|
||
| Cancer Research Technology |
|
|
|||
| Eurazeo |
|
|
|||
| Johnson & Johnson JJDC |
|
|
|||
| Kurma Partners |
|
|
Oncode Oncology Bridge Fund FAQs
-
What is Oncode Oncology Bridge Fund?
Founded in 2018, Oncode Oncology Bridge Fund is a venture capital fund based in Utrecht, Netherlands.
-
When was Oncode Oncology Bridge Fund founded?
Oncode Oncology Bridge Fund was founded in 2018.
-
Where is Oncode Oncology Bridge Fund headquartered?
Oncode Oncology Bridge Fund is headquartered in Utrecht, Netherlands.
-
How many investments has Oncode Oncology Bridge Fund made?
Oncode Oncology Bridge Fund has made 14 investments.
-
What has Oncode Oncology Bridge Fund invested in?
Oncode Oncology Bridge Fund has made numerous investments in companies like Laigo Bio, Cyclomics, and Flindr Therapeutics within the Drug Discovery and Biotechnology industries.
-
What has Oncode Oncology Bridge Fund invested in recently?
Oncode Oncology Bridge Fund's latest investment was on 20-Mar-2026 in Laigo Bio, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process